Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.
about
Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) miceFoxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathwaysThe PD-1 pathway in tolerance and autoimmunityCentral role of defective interleukin-2 production in the triggering of islet autoimmune destructionHuman T regulatory cell therapy: take a billion or so and call me in the morningTh17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut MicrobiomeCorrelations between psoriasis and inflammatory bowel diseasesInhibition of Autoimmune Diabetes in NOD Mice by miRNA TherapyConcise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 DiabetesAntigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune DiseasesDeficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis.B cell deficient mice are protected from biliary obstruction in the rotavirus-induced mouse model of biliary atresia.At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction.APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development.Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation.Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjectsVirus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.The type of responder T-cell has a significant impact in a human in vitro suppression assay.Association of increased Treg and Th17 with pathogenesis of moyamoya disease.The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation.Apoptosis of purified CD4+ T cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice.Autoimmune effector memory T cells: the bad and the goodAutoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis.Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.Prediction and pathogenesis in type 1 diabetes.A novel pancreatic β-cell targeting bispecific-antibody (BsAb) can prevent the development of type 1 diabetes in NOD miceNaturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppressionDecreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitisRapid temporal control of Foxp3 protein degradation by sirtuin-1.Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity.Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD miceImpaired thymic export and apoptosis contribute to regulatory T-cell defects in patients with chronic heart failureDendritic cell-targeted pancreatic beta-cell antigen leads to conversion of self-reactive CD4(+) T cells into regulatory T cells and promotes immunotolerance in NOD mice.Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.Immunomodulation of antigen presenting cells promotes natural regulatory T cells that prevent autoimmune diabetes in NOD mice.Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice.Changes in the levels of cytokines in both diabetic/non-diabetic type I children living in a moderate altitude area in Saudi Arabia.Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Opposing effects of CTLA4 insufficiency on regulatory versus conventional T cells in autoimmunity converge on effector memory in target tissue.
P2860
Q21562482-F2CF2026-21E7-4D3C-B706-39B390F6C8FFQ24323279-4BB23341-679F-4002-92CA-7B18B17C875BQ24633549-66471D73-61B0-4FD2-89F0-7025952A9FCFQ24650734-E418EA4A-D26B-4A71-9719-504904621DE2Q24656069-976A7D76-AA20-4229-BB96-8889C0FEF229Q26769612-9B0EA897-044D-43E0-8680-73F5023AFFAFQ27024863-A05771AA-7016-4156-B074-CEF7095C18D2Q27334532-0857633B-D6C2-4483-96E4-182A22846E58Q28071490-D647EA00-24ED-41B4-B0CD-945930A5E515Q28080791-34E1913C-198E-4503-A577-83D829E4652DQ30437183-435BF573-A090-4D69-9734-57EC3057DE68Q31133805-C278D744-4EFD-4B4A-8581-CED4D72DF077Q33268352-F3D6C4E0-0870-48C7-B3C7-A862BC700690Q33384634-887FD6E7-9AD2-4D98-BA36-D0E8A4E2F1E4Q33490627-01F279DD-2E03-4624-B2AE-21323D4D98E1Q33604570-8E1C577E-5E9D-4769-B515-63E349FCA1C8Q33768325-6448E03B-6E9A-4E22-ADC8-38C89A06BDAFQ33769528-579C9042-284C-4763-BC9D-0CD1FC3EA378Q33780428-1DBE3F1A-119F-4CF9-BC6C-9D8F3AA83035Q33784558-82F2B6A6-9B0C-4A68-8E4B-D28A1CC2D53CQ33786819-456A7BCE-2EEC-4783-A295-011B33FC480AQ33794691-2E858716-4837-4439-9735-F17946034082Q33811669-7ACD0C06-0D6E-4E9E-982D-7610FD5CC4A0Q33811894-9E0FA24E-1238-47C5-99A4-BEDCEFA89EA6Q33818896-0EEF54D8-9E59-4E92-89FF-D12E5EE99D32Q33829266-272A8828-213F-421D-89AF-F5870580F01BQ33869793-7FFC1D78-7DC9-49BE-B8BC-9E84AFCA3324Q33873640-50CC3F4D-DA2F-454D-B823-0271EE456C4EQ33886284-A5DAF6E1-9B39-42DA-9497-0057EB86B9A6Q33918375-B14F9079-BF2F-4B77-906A-253AF3F975DAQ33930268-5D5D8450-1CC6-40EE-A456-B644C00E3E8AQ33955180-915432D0-3409-4EC3-984E-28ACF0284425Q34026055-2B151364-61CA-4F68-A4C1-D524EAA58923Q34072331-8CB72873-CAD6-44C7-BA7E-03DCC7CED47AQ34159981-34F71845-0E26-443D-8FDD-5E504BE524A0Q34166274-A53EAD09-78A4-4ADB-8784-7CFA8505A3C1Q34200740-7E553319-83B9-47E4-8C9D-4A7F26A273DDQ34240811-A0ED7209-3085-43F7-A732-898568CCAB00Q34350546-81EAAD56-963A-417A-BC47-15B1D7651171Q34364752-2F271718-5F67-43A4-A204-C01003627A43
P2860
Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Defective suppressor function in CD4
@nl
Defective suppressor function ...... patients with type 1 diabetes.
@ast
Defective suppressor function ...... patients with type 1 diabetes.
@en
type
label
Defective suppressor function in CD4
@nl
Defective suppressor function ...... patients with type 1 diabetes.
@ast
Defective suppressor function ...... patients with type 1 diabetes.
@en
prefLabel
Defective suppressor function in CD4
@nl
Defective suppressor function ...... patients with type 1 diabetes.
@ast
Defective suppressor function ...... patients with type 1 diabetes.
@en
P2093
P50
P356
P1433
P1476
Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes
@en
P2093
Amanda Bishop
Bart O Roep
Shelley Lindley
P356
10.2337/DIABETES.54.1.92
P407
P577
2005-01-01T00:00:00Z